25-OH Vitamin D: Evidence-Based Ways to Improve Your Level

What 25-OH Vitamin D Actually Measures

The 25-hydroxyvitamin D blood test (also written as 25(OH)D) is the standard biomarker for total body vitamin D status. Your liver converts dietary and sun-derived vitamin D into 25-hydroxyvitamin D, the circulating storage form with a half-life of approximately 15 days [1]. This is the form that clinicians order because it reflects cumulative intake from all sources (supplements, food, and UVB exposure) over the prior 4 to 8 weeks.

A common point of confusion: 25-OH vitamin D is not the active hormone. The kidneys convert it into 1,25-dihydroxyvitamin D (calcitriol), which regulates calcium absorption and bone remodeling. But calcitriol has a short half-life of about 4 to 6 hours, making it a poor marker for overall stores [2]. Ordering the wrong test can lead to a false sense of adequacy. The Endocrine Society's 2024 guideline reaffirms that 25(OH)D is the only appropriate screening assay for vitamin D status.

Two assay formats exist: immunoassay and liquid chromatography-tandem mass spectrometry (LC-MS/MS). LC-MS/MS separately quantifies D2 and D3 metabolites, which matters when a patient takes ergocalciferol (D2). If your lab reports only total 25(OH)D, both forms are summed.

Normal Ranges and What the Guidelines Say

The answer depends on which guideline you follow. That tension is worth understanding before you choose a dose.

The Institute of Medicine (now the National Academies) set 20 ng/mL as sufficient for bone health in the general population, noting that 97.5% of people meet skeletal calcium needs at this threshold [3]. The Endocrine Society historically defined sufficiency as 30 ng/mL and above, with deficiency below 20 ng/mL and insufficiency between 20 and 29 ng/mL [4]. Their updated 2024 guideline acknowledges the population-level 20 ng/mL threshold while still recommending that higher-risk groups (older adults, patients with osteoporosis, those with malabsorption) target at least 30 ng/mL.

Dr. Michael Holick, a professor of medicine at Boston University who has published over 500 papers on vitamin D metabolism, has stated: "A blood level of 40 to 60 ng/mL is the preferred range for maximizing the non-skeletal benefits of vitamin D, including immune regulation and muscle function" [5].

The practical takeaway for most HealthRX patients: if your level is below 30 ng/mL, a systematic correction plan is warranted. If it is between 30 and 50 ng/mL, modest daily supplementation (1,000 to 2 to 000 IU) is reasonable. Levels above 50 ng/mL rarely require additional supplementation.

Step 1: Correct Deficiency with a Loading Protocol

For patients with confirmed deficiency (25(OH)D <20 ng/mL), the Endocrine Society recommends 50 to 000 IU of ergocalciferol (D2) or cholecalciferol (D3) once weekly for 6 to 8 weeks, followed by a maintenance dose of 1,500 to 2 to 000 IU daily [4]. This is not a suggestion reserved for severe cases. It is the standard repletion protocol.

Cholecalciferol (D3) is preferred over ergocalciferol (D2) in most contexts. A meta-analysis of 7 RCTs (N=804) published in the American Journal of Clinical Nutrition found that D3 raised serum 25(OH)D levels approximately 87% more effectively than D2 and maintained those levels 2 to 3 times longer [6]. D2 is still appropriate for strict vegans (as plant-derived D2 comes from irradiated yeast), but D3 derived from lichen is now widely available as a vegan alternative.

One loading protocol studied in the BMJ tested a single mega-dose of 500 to 000 IU annually. The result was paradoxical: the high-dose group had a 15% increase in falls and a 26% increase in fractures compared to placebo (N=2,256 community-dwelling women aged 70 and older) [7]. Bolus dosing above 60 to 000 IU at one time is now discouraged by most clinical guidelines.

Step 2: Establish a Daily Maintenance Dose

After repletion, the right maintenance dose depends on your body weight, baseline level, and absorption status. Here is a dose-response framework based on pooled data.

Each 1 to 000 IU of daily D3 raises 25(OH)D by roughly 6 to 10 ng/mL over 2 to 3 months in normal-weight adults [8]. That means a 140-pound person starting at 22 ng/mL could reach 32 to 42 ng/mL on 2 to 000 IU daily. A person at the same starting level who weighs 240 pounds might need 4,000 to 5 to 000 IU daily to achieve the same result, because vitamin D is fat-soluble and distributes into adipose tissue.

The Endocrine Society guideline specifically notes that obese individuals (BMI ≥30) may require "2 to 3 times more vitamin D to satisfy their body's requirement" compared to normal-weight counterparts [4]. This is not speculative. A dose-finding trial by Gallagher et al. (N=163) published in Annals of Internal Medicine confirmed that BMI was the single strongest predictor of dose requirement, and women with BMI above 30 needed a mean of 4 to 200 IU/day to maintain levels above 30 ng/mL [9].

Practical dosing tiers for maintenance:

• Normal weight (BMI <25): 1,500 to 2 to 000 IU/day
• Overweight (BMI 25 to 29.9): 2,000 to 3 to 000 IU/day
• Obese (BMI ≥30): 3,000 to 5 to 000 IU/day
• Post-bariatric surgery or malabsorption: 5,000 to 10 to 000 IU/day under physician monitoring

Always take vitamin D with a meal containing fat. A study by Dawson-Hughes et al. found that taking vitamin D with the largest meal of the day (which typically contains the most fat) increased absorption by approximately 50% compared to taking it on an empty stomach [10].

Step 3: Optimize Sun Exposure (Within Limits)

Sunlight is the original source. When UVB radiation (wavelength 290 to 320 nm) strikes the skin, 7-dehydrocholesterol converts to previtamin D3. Roughly 10 to 30 minutes of midday sun exposure on the face, arms, and legs two to three times per week can produce 10,000 to 20 to 000 IU of vitamin D3 in fair-skinned individuals [5]. That number drops dramatically with darker skin pigmentation, sunscreen use, higher latitudes, and winter months.

The WHO and CDC do not endorse unprotected sun exposure as a primary vitamin D strategy due to skin cancer risk [11, 12]. The practical middle ground: if you live below the 37th parallel (roughly south of San Francisco, St. Louis, or Richmond) and have a Fitzpatrick skin type I to III, 10 to 15 minutes of unprotected midday sun on arms and legs a few times per week during spring through fall can meaningfully contribute to your vitamin D production. For everyone else, or during winter months, supplementation is more reliable.

A critical detail: UVB rays do not penetrate glass. Sitting near a sunny window does not generate vitamin D. And SPF 30 sunscreen blocks approximately 95 to 98% of UVB, effectively halting cutaneous vitamin D synthesis [13].

Step 4: Add Dietary Sources

Diet alone rarely corrects deficiency. Few foods contain meaningful amounts of vitamin D. But dietary sources can contribute 200 to 600 IU per day, which helps sustain levels once you have repleted.

The richest natural sources per 3-ounce serving: wild-caught salmon provides 600 to 1 to 000 IU, canned sockeye salmon about 570 IU, sardines roughly 165 IU, and a single egg yolk about 40 IU [14]. Farmed salmon contains significantly less vitamin D than wild-caught, sometimes 75% less, due to differences in feed composition.

Fortified foods add modest amounts. One cup of fortified milk or orange juice typically contains 100 to 120 IU. Fortified cereals range from 40 to 100 IU per serving. UV-exposed mushrooms (now sold in many grocery stores) can provide 400 to 800 IU per serving, though this is primarily D2, which, as noted above, is less potent at raising serum levels [6].

The National Institutes of Health Office of Dietary Supplements provides a complete nutrient database. Their recommended dietary allowance (RDA) of 600 IU for adults under 70 and 800 IU for adults 71 and older was set by the IOM in 2011, but the Endocrine Society and the American Association of Clinical Endocrinologists (AACE) consider these values insufficient for patients already found to be deficient [4, 15].

The Role of Vitamin K2 and Magnesium

Two cofactors deserve attention because they influence how well your body uses the vitamin D you take.

Magnesium is required for the enzymatic conversion of vitamin D into its active form. A cross-sectional analysis from the NHANES dataset (N=12,284) found that adequate magnesium intake was significantly associated with reduced risk of vitamin D deficiency and insufficiency [16]. The American Osteopathic Association published a review noting that "vitamin D supplementation without adequate magnesium can be ineffective" because the enzymes that metabolize vitamin D (hepatic 25-hydroxylase and renal 1α-hydroxylase) are magnesium-dependent [17]. Good magnesium sources include pumpkin seeds (156 mg per ounce), spinach (157 mg per cup cooked), and magnesium glycinate supplements (typical dose: 200 to 400 mg/day).

Vitamin K2 (menaquinone-7) directs calcium into bones and away from arterial walls. While no large RCT has definitively proven that adding K2 to vitamin D supplementation improves bone outcomes beyond vitamin D alone, a 3-year trial in postmenopausal women (N=244) showed that K2 (180 mcg/day MK-7) reduced age-related bone mineral density loss at the lumbar spine and femoral neck [18]. Many clinicians now recommend 100 to 200 mcg of MK-7 alongside vitamin D supplementation, especially in patients at risk for vascular calcification.

When to Retest and What to Watch For

Retest 25(OH)D at 3 months after starting supplementation or changing dose. Testing earlier is unreliable because it takes 8 to 12 weeks for serum levels to stabilize at the new steady state [4].

If your level has not improved after 12 weeks on an adequate dose, consider these factors: malabsorption (celiac disease, Crohn's, history of gastric bypass), liver disease (impaired 25-hydroxylation), medication interference (phenytoin, phenobarbital, and carbamazepine accelerate vitamin D catabolism through CYP450 induction), or simple non-adherence.

The USPSTF does not recommend universal screening for vitamin D deficiency in asymptomatic adults, stating that current evidence is insufficient to assess the balance of benefits and harms [19]. However, testing is clearly indicated in patients with osteoporosis, chronic kidney disease, malabsorption syndromes, obesity, unexplained muscle weakness, or frequent falls.

When Vitamin D Is Too High

Toxicity from vitamin D is rare but real. It does not occur from sun exposure (the body self-regulates cutaneous production) and is exceedingly unlikely at daily doses below 10 to 000 IU [4]. Documented toxicity typically involves prolonged intake exceeding 40,000 to 50 to 000 IU/day or manufacturing errors in supplements.

The hallmark of vitamin D toxicity is hypercalcemia. Symptoms include nausea, vomiting, polyuria, confusion, and in severe cases, renal failure and cardiac arrhythmias. A 25(OH)D level above 100 ng/mL is the usual threshold where hypercalcemia risk becomes clinically relevant [20]. Levels between 50 and 100 ng/mL are not associated with toxicity in most studies but offer no proven additional benefit for most patients [3].

If your 25(OH)D is above 80 ng/mL without a clinical reason (such as granulomatous disease requiring monitoring), reducing or stopping supplementation and rechecking in 3 months is the standard approach.

Special Populations

Older adults (65+): Skin production of vitamin D declines by approximately 75% between age 20 and age 70 [5]. The American Geriatrics Society recommends at least 4 to 000 IU of vitamin D daily for adults aged 65 and older to achieve serum levels of 30 ng/mL or above, a dose well above the IOM RDA of 800 IU [21].

Darker skin tones: Melanin reduces UVB-mediated vitamin D synthesis by 50 to 90% compared to Fitzpatrick type I skin. NHANES data show that 82% of non-Hispanic Black Americans and 63% of Hispanic Americans have 25(OH)D levels below 20 ng/mL, compared to 31% of non-Hispanic white Americans [22]. Supplementation rather than sun exposure is the primary corrective strategy for these groups.

Pregnant and lactating women: The American College of Obstetricians and Gynecologists (ACOG) recommends 600 IU/day as the minimum, though many experts advocate for 2,000 to 4 to 000 IU/day during pregnancy based on data from a trial by Hollis et al. (N=350) showing that 4 to 000 IU/day safely achieved levels above 40 ng/mL without adverse effects in pregnant women [23, 24].

Patients on GLP-1 receptor agonists: Rapid weight loss from medications like semaglutide or tirzepatide can release stored vitamin D from adipose tissue, transiently raising serum levels. However, as fat mass decreases, the body's vitamin D storage capacity also decreases, and patients may need dose adjustments during active weight-loss phases. Monitor 25(OH)D every 3 to 6 months during GLP-1 therapy.

A Concrete 12-Week Action Plan

Week 1 through 8: If your 25(OH)D is below 20 ng/mL, take 50 to 000 IU of D3 once weekly (or 7 to 000 IU daily, which is pharmacokinetically equivalent). If your level is 20 to 29 ng/mL, start with 4,000 to 5 to 000 IU of D3 daily. Take each dose with your largest meal.

Week 1 onward (concurrent): Add 200 to 400 mg of magnesium glycinate daily and 100 to 200 mcg of vitamin K2 (MK-7) daily. Get 10 to 15 minutes of midday sun on arms and legs 2 to 3 times weekly if your location and skin type allow.

Week 9 through 12: Transition from loading dose (if used) to maintenance of 2,000 to 5 to 000 IU daily based on your body weight.

Week 12: Retest 25(OH)D. Target: 40 to 60 ng/mL. If still below 30 ng/mL, repeat the loading protocol and investigate malabsorption or medication interactions. If between 30 and 50 ng/mL, continue the current maintenance dose and retest annually.